Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland
· Delayed Price · Currency is CHF 13.16
-0.26 (-1.94%)
May 13, 2025, 4:00 PM CET
Santhera Pharmaceuticals Holding AG Employees
Santhera Pharmaceuticals Holding AG had 79 employees as of December 31, 2024. The number of employees increased by 34 or 75.22% compared to the previous year.
Employees
79
Change (1Y)
34
Growth (1Y)
75.22%
Revenue / Employee
495.15K CHF
Profits / Employee
-531.32K CHF
Market Cap
172.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Lonza Group AG | 18,944 |
| Alcon | 25,599 |
| Galderma Group AG | 6,545 |
| Straumann Holding AG | 11,815 |
| Sandoz Group AG | 22,049 |
| Sonova Holding AG | 18,151 |
Santhera Pharmaceuticals Holding AG News
- 14 days ago - Santhera Pharmaceuticals reports FY results - Seeking Alpha
- 2 months ago - Santhera Pharmaceuticals reports FY results - Seeking Alpha
- 4 months ago - Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia - GlobeNewsWire
- 4 months ago - Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group - GlobeNewsWire
- 5 months ago - Santhera Announces Approval from China's NMPA for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy - Benzinga
- 8 months ago - Santhera Pharmaceuticals reports 1H results - Seeking Alpha
- 8 months ago - Santhera Enters into an Exclusive Distribution Agreement with GENESIS Pharma for AGAMREE® (Vamorolone) in Central and Eastern Europe - GlobeNewsWire